Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.
about
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsNuclear Receptor Regulation of Aquaporin-2 in the KidneyThiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium RetentionPPAR-γ -- a possible drug target for complicated pregnanciesMegalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal functionRole of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cellsThe antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAILDifferential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mousePeroxisomes and Kidney InjuryRole of G protein-coupled receptor kinase-2 in peroxisome proliferator-activated receptor gamma-mediated modulation of blood pressure and renal vascular reactivity in SHR.Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retentionRegulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsNuclear receptors in renal diseaseAntidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.Idealized PPARγ-Based Therapies: Lessons from Bench and BedsideThe role of nuclear receptors in the kidney in obesity and metabolic syndromePeroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblastsPPAR Action in Human Placental Development and Pregnancy and Its Complications.Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsInteraction Effects of the Leu162Val PPAR α and Pro12Ala PPAR γ 2 Gene Variants with Renal Function in Metabolic Syndrome Population.Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsPeroxisome proliferator-activated receptors in diabetic nephropathy.Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Orphan nuclear receptors as targets for drug development.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulinDNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy.Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.Troglitazone induces extracellular matrix and cytoskeleton remodeling in mouse collecting duct cells.Role of PPARα and Its Agonist in Renal Diseases.Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in ratsThe Rate of Decline of Glomerular Filtration Rate May Not Be Associated with Polymorphism of the PPARγ2 Gene in Patients with Type 1 Diabetes and Nephropathy.Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
P2860
Q24314509-F70AAB59-DD4C-4335-A507-366D417E434EQ26740554-5E8C15D1-A0C7-4DE4-9A40-475F0705396EQ26851905-4D7E1D2E-CFCE-4F22-9ECD-17334FDB1522Q26863678-62F065E7-3559-49DF-BF65-3760C1491A64Q27437610-117DE909-AA64-4FB9-A5D9-5EBDC01F3E69Q28345289-DF624611-A034-4784-A94C-988CDEC29E1EQ28478349-21F18FFF-95AD-4296-9054-9CDA44F8A2A4Q28585053-6942A96B-94E6-40B6-9D34-944267745825Q28595714-44FDEB94-DB8E-485C-AD8A-2B2B05708D57Q33440398-F8DFBE26-35FE-4A4E-B5CA-A2BEDB44DE4FQ33878917-534AE67B-5082-4C3E-AE0F-20D4DEAE5BE1Q33960919-FF085B81-1ABE-4B46-92AB-6FCB3DE2604CQ35120702-283F8DAF-61B9-4B4D-BDED-BBA2445D0775Q35596926-68D14A2B-CA3D-4B9B-B564-A2E13DFB9CD1Q35677086-EBF655A8-B402-4851-9508-0093864B8CF8Q35964478-AAE629D4-04D3-4251-9BE7-AAB8E732AF31Q36056207-34406531-4D7B-4967-8C01-B49296B6D0DBQ36250127-3B9147D2-2E41-49F4-8567-34D09EAA67BCQ36417662-97BD50A0-D42B-49BC-8619-473A05A4A9CCQ36446678-17B82E63-AEFC-4FB3-9E49-37F202C8DE91Q36583366-CBAD3AD0-55A5-49C3-8B43-97BBA199B62DQ36733873-886E4ECE-776A-4F75-B5EA-B7302EC9FA08Q36830957-3176518E-5D5D-415B-B1D3-7546CDBA4CD7Q36982658-709D48D9-6233-4128-A803-A2AE58B7BEFCQ37077098-FEDDA239-71B5-4015-A3B5-9F5749366913Q37412297-3DE229BB-7ACA-4590-A4AF-8D9988A1AB3EQ37699907-4BD5704A-1776-429C-92C8-F64DCCAF47F8Q37725708-2A60E511-B6FE-4FD5-AFDB-3536E216DB6BQ37933675-2554DF3F-F7E2-4CCE-AC16-CA49B20CCB41Q37997004-A09B1A2E-D965-4AFA-9E07-60DFBB215683Q38289039-07965EC4-13DA-4DC3-B7E2-DA43958533FAQ38446580-907DA976-6C85-4831-8389-8A42A57FF989Q38546383-A0F3C6A2-3289-4238-857A-A7DECC4FC2F3Q38735354-90BE8E8A-CB81-4421-92DD-71F84AF597AAQ39364983-762373F9-CA33-49B3-8282-7B8590AD6B53Q39817316-BC8E8A7C-A2B2-4764-AF4D-F479CC4E293DQ40048496-2219C4A4-B551-4B9A-8655-D560D7F775D4Q41447058-2F736EC5-939E-4421-9E70-A7916A3453B2Q41824160-5780178B-776A-4261-A78F-9774238E2FACQ41970353-D6294435-D1D4-44A6-8870-C3324214E5E4
P2860
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Expression of peroxisome proli ...... y tract of rabbits and humans.
@en
Expression of peroxisome proli ...... y tract of rabbits and humans.
@nl
type
label
Expression of peroxisome proli ...... y tract of rabbits and humans.
@en
Expression of peroxisome proli ...... y tract of rabbits and humans.
@nl
prefLabel
Expression of peroxisome proli ...... y tract of rabbits and humans.
@en
Expression of peroxisome proli ...... y tract of rabbits and humans.
@nl
P2093
P1476
Expression of peroxisome proli ...... y tract of rabbits and humans.
@en
P2093
P304
P407
P433
P577
1997-12-01T00:00:00Z